The annual meeting of the American College of Allergy, Asthma & Immunology was held from Nov. 6 to 10 in Orlando, Florida, ...

In Evaluate’s recently released annual World Preview Report, including updated global pharmaceutical market projections ...

Hospitalization for infections significantly increases long-term dementia risk, highlighting the need for prevention and ...

Johnson & Johnson (JNJ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM ESTCompany ParticipantsCandice Long - Worldwide ...

Lunai Bioworks , an AI-powered drug discovery and biodefense company, today announced it has secured its first Letter of Intent (LOI) to license its next-generation immune cell therapy, which achieved ...

Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

When the immune system attacks the brain, behavior is a symptom, not defiance. Kids with neuroimmune disease are falling ...

Researchers Alicia Gibbons and Amparo Martinez Pérez of the La Jolla Institute for Immunology have been awarded WHAM Edge ...

Topline results from the phase 3 HERIZON-GEA-01 trial show that the HER2-targeted bispecific antibody zanidatamab-hrii ...

ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...

The assignment of the non-proprietary name represents an important step in the development and potential future commercialization of our CAR-T therapy. The INN naming process meticulously evaluates ...